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REPAIR OF CHORDAE 
TENDINEAE FOR 
RHEUMATIC MITRAL 
VALVE DISEASE 
A twenty-year experience 
Sixty-two patients with rheumatic mitral valve disease (mean age 42.2 - 
10.2 years) underwent repair of chordae tendineae between June 1974 and 
May 1994. Chordal shortening was done in 38 patients, fenestration i 17, 
resection of secondary chordae in 3, replacement in 2, and transposition i
2. In 41 patients, mitral commissurotomy was also done. Ring annuloplasty 
was done in all patients. The mean follow-up was 10.2 years (range 2 
months to 20 years). The completeness of follow-up during the closing 
interval (January to July 1994) was 100%. Hospital mortality occurred in 
four patients (6.5%) and nine patients died during the late follow-up. The 
actuarial survival curve at 20 years was 65.8% - 10%. Six patients with 
mitral valve dysfunction (restenosis 4, insufficiency 2) and one with aortic 
valve dysfunction (structural deterioration of bioprosthesis) underwent 
reoperation. The actuarial curve of freedom from reoperation at 20 years 
for mitral valve dysfunction was 73.1% -+ 10.5%. In the 49 surviving 
patients, a Doppler echographic study during the closing interval showed a 
mean mitral valve area of 1.9 + 0.3 cm 2. In the 43 patients with a repaired 
native valve, absent or trivial mitral regurgitation was documented in 35 
and mild or moderate regurgitation i 8. In conclusion, repair of chordae 
tendineae in rheumatic mitral valve disease when feasible is a stable and 
safe procedure with a low prevalence of reoperation. However, the type of 
reconstructive operation and experience of the surgical team are major 
considerations in successful repair of the mitral valve. (J THORAC CARDIO- 
VASC SURG 1996;111:211-7) 
José M. Bernal, MD, José M. Rabasa, MD, Juan J. Olalla, MD, 
Manuel F. Carrión, MD, Alicia Alonso, MD, and José M. Revuelta, MD, 
Santander, Spain 
A lthough mitral valve reconstruction has been shown I-o provide better results than valve re- 
placement, 1-3 there is a paucity of proper compari- 
sons as to the long-term stability of the results 
obtained with different reparative operations. Tech- 
nical difficulties in the repair of the subvalvular 
apparatus and the limited experience with this type 
of complex operation have been major impediments 
to the widespread repair, rather than replacement, 
of the incompetent mitral valve. On the other hand, 
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most of the reports rend to describe the results of 
repair in a mixed population with different causes of 
the valve disease. 4'5 This report retrospectively an- 
alyzes the results obtained in a 20-year period in 
patients with rheumatic valvular disease who under- 
went repair of chordae tendineae. 
Patients and methods 
Between June 1974 and May 1994, 354 patients with 
rheumatic mitral valve disease, excluding those with pure 
mitral stenosis treated by isolated open mitral commissur- 
otomy, papillary muscle split, or both, underwent an 
operation for mitral valve reconstruction with a ring 
nnuloplasty at our institution. Repair of chordae tendi- 
neae in association with mitral valve annuloplasty was 
done in 62 (17.5%) of 354 patients. The patient selection 
criteria were based exclusively on intraoperative findings 
and feasibility of repairing the subvalvular apparatus. 
Data in these 62 patients constitute the basis for this 
report. 
There were 14 men and 48 women with a mean age of 
42.2 _+ 10.2 years (range 18 to 73 years). At the time of 
operation, 19 (30.6%) patients were in New York Heart 
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Table I. Mitral vaIve lesions in 62 patients 
undergoing repair of chordae tendineae 
No. of 
Anatomic lesion patients Percent 
Annular dilatation 26 41.9 
Commissural fusion 30 48.4 
Leaflet calcification 4 6.5 
Leaflet retraction 4 6.5 
Chordal elongation 38 61.3 
Subvalvular pparatus fusion 19 30.6 
Chordal rupture 5 8.1 
Association functional class II, 34 (54.8%) in class III, and 
9 (14.5%) in class IV. Before operation, 14 (22.6%) 
patients were in sinus rhythm and 48 (77.4%) in atrial 
fibrillation. Forty-two (67.7%) patients had an isolated 
mitral valve lesion, 17 (27.4%) an associated tricuspid 
valve lesion, 1 (1.6%) an associated aortic valve lesion, 
and 2 (3.2%) triple valve disease. 
The mitral valve disease consisted of combined stenosis 
and insufficiency in 25 (40.3%) patients and mixed lesions 
with predominant insufficiency in 37 (59.7%). Preopera- 
tive evaluation included cardiac catheterization i 30 
(48.4%) patients, echocardiography in 15 (24.2%), or both 
in 17 (27.4%). In 47 patients mean systolic pulmonary 
artery pressure was 41.4 _+ 12.1 mm Hg and mean mitral 
transvalvular gradient was 8.4 _+ 5.3 mm Hg. 
Intraoperative t sting of mitral valve competence and 
surgical procedures used for valve repair have already 
been described, 6-9 and recently the use of transesophageal 
Doppler echocardiographic study has been reported. Mi- 
tral valve findings are described in Table I. The mitral 
anulus was found to be dilated in 41.9% of patients, the 
mitral leaflets were affected in 61.3% of patients, and the 
commissures were fused in 48.4% of patients. Rheumatic 
lesions of chordae tendineae were found in all patients. 
These involved marginal chordae in 59 (95.2%) patients 
and medial (secondary) chordae in the remaining 3 
(4.8%). Chordal elongation was present in 61.3% of cases, 
severe fusion in 30.6%, and rupture in 8.1%. 
The type of technique used for mitral valve repair is shown 
in Table II. The Duran flexible ring was used in 95.2% of 
patients and the rigid Carpentier ing in 4.8%. A total of 
66.1% of patients underwent open commissurotomy and 
4.8% underwent partial eaflet resection. Chordal shortening 
was done in 61.3% of patients, fenestration in 27.4%, 
secondary chordal resection in 4.8%, replacement 1° in 3.2%, 
and transposition in 3.2%. A total of 170 mitral valve 
reparative procedures were done in 62 patients, for an 
average of 2.7 procedures per patient. Operations on other 
valves included tricuspid valve repair in 19 patients (Duran 
flexible ring annuloplasty in 19, concomitant tricuspid com- 
missurotomy in 7) and aortic valve operation in 2 (biopros- 
thesis 1, valve repair 1). Myocardial revascularization was 
done in three patients, atrial septal defect closure in two, left 
atrial thrombectomy in six, left atrial appendage exclusion in 
eight, and other cardiae procedures in four. 
Surviving patients in sinus rhythm were given antiplate- 
let therapy for 3 months after the operation (n = 12). 
Those patients with atrial fibrillation received crystalline 
Table II. Surgical techniques in 62 patients with 
rheumatic mitraI valve disease undergoing repair of 
chordae tendineae 
No. of 
Operation patients Percent 
Annular repair* 62 100 
Commissurotomy 41 66.1 
Leaflet resection 5 8.1 
Chordal shortening 38 61.3 
Chordal fenestration 17 27.4 
Chordal resection 3 4.8 
Chordal replacement 2 3.2 
Chordal transposition 2 3.2 
*Flexible ring annuloplasty, 59 patients; rigid ring annuloplasty, 3 patients. 
warfarin sodium (Coumadin) for 3 months after operation 
(n = 35) or on a long-term basis when the patient was 
considered to be at especially high risk for late thrombo- 
embolic complications because of a giant left atrium or 
massive thrombus (n = 11). However, this thromboem- 
bolic prophylaxis was modified according to the patient's 
requirements during follow-up. 
Follow-up of all surviving patients was done at regular 
intervals of 3, 6, and 12 months after operation and then 
annually. Follow-up was completed from January to July 
1994. The completeness of follow-up during the closing 
interval was 100%. All patients were seen at our outpa- 
tient clinic and had a Doppler echographic study during 
the closing interval. The mean follow-up was 10.2 years, 
with a range from 2 months to 20 years. 
The values are expressed as means of the average and 
standard eviation. The X 2 test was used to analyze the 
significance between variables. Actuarial curves were ob- 
tained by the life-table method. 
Results 
Hospital mortality occurred in four (6.4%) pa- 
tients. The causes of death were heart failure in two 
patients and massive hemorrhage in two. Hospital 
mortality for patients undergoing isolated mitral 
valve operation was 4.8% (2/42) and for patients 
having polyvalvular operations 10% (2/20) (p = not 
significant). 
Of the 58 surviving patients, nine died during the 
late follow-up (15.5%). The causes of death were 
heart failure in three patients, thromboembol ism in 
orte, noncardiac death in one, and unknown in four. 
The actuarial survival curve at 20 years was 65.8% + 
10% (Fig. 1). For the group of 42 patients who 
underwent isolated mitral valve repair, the actuarial 
survival curve at 20 years was 75.3% _+ 13.3%, 
whereas for the 20 patients who had polyvalvular 
operation it was 52.1% -- 18.6% (p = not signifi- 
cant) (Fig. 2). 
Nine patients had a thromboembol ic episode 
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Fig. 1. Actuarial probability of survival after mitral valve repair. Number above x-axis represents otal 
number of patients at risk. 
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Fig. 2. Actuarial probability of survival in patients with isolated mitral valve lesions (squares) and in patients 
witk multiple valve lesions (asterisks). Number above x-axis represents otal number of patients at risk. 
during the follow-up: two peripheral and seven 
central (4 transient, 2 with permanent neurologic 
impairment, and 1 death). The actuarial survival 
curve for freedom from thromboembolic events at 
20 years was 74.3% _+ 7.7% (Fig. 3). There were no 
statistically significant differences in survival free 
from thromboembolic events between patients with 
isolated mitral valve repair and patients with poly- 
valvular disease or between patients with or without 
anticoagulation r those in atrial fibrillation or sinus 
rhythm. 
Seven patients required a valve reoperation. The 
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Fig. 3. Survival free from thromboembolic events. Number above x-axis represents total number of 
patients at risk. 
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Fig. 4. Survival free from reoperation. Number above x-axis represents otal nmnber of patients at risk. 
reoperation was necessary because of mitral valve 
dysfunction in six patients (stenosis in 4 after an 
interval of 194 _+ 33.2 months, mitral insufficiency in
2 after an interval of 51 ± 33.7 months) and because 
of structural deterioration of the aortic bioprosthe- 
sis in one. There was no mortality at reoperation. 
The actuarial curve of freedom from reoperation at 
20 years for mitral valve dysfunction was 73.1% +_ 
10.5% (Fig. 4). Other valve-related complications 
such as infective ndocarditis or ring dehiscence did 
not occur. The actuarial curve of freedom from 
valve-related complications at20 years was 47.1% ± 
9.4% (Fig. 5). Linear rates of valve-related compli- 
cations were 4.2% _+ 1.2% per patient-year. Statis- 
tically significant differences in survival free from 
reoperation and survival free from valve-related 
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Fig. 5, Survival free from valve-related complications. Number above x-axis represents total number of 
patients at risk. 
complications between patients with isolated mitral 
operation and th0se with polyvalvular disease were 
not found~ 
Forty-three (87.8%) of the 49 surviving patients at 
the closing interval of follow-up had the repaired 
native mitral valve and were in functional class I or 
II. In these 43 patients, mean left ventricular systolic 
diameter was 29.5 _+ 6.8 mm and rnean diastolic 
diameter 48.4 _+ 6.2 mm. Mean left ventricular 
ejection fraction was 61.7% _+ 9.8% and mean left 
atrial diameter was 43.7 _+ 10.5 mm. The mean 
mitral valve area was 1.9 + 0.3 cm2. Absent or trivial 
mitral regurgitation was documented in 35 (81.4%) 
patients and mild or moderate regurgitation i  8 
(18.6%). 
Discussion 
Although data from different reports have con- 
firmed the predictability and stability of the results 
achieved with reconstructive procedures of the mi- 
tral valve, 1' 1~, ~2 repair of chordae tendineae is done 
occasionaHy and only by some surgical teams. In 
most patients, Valve replacement continues to be a 
widely accepted äpproach for rheumatic disease 
because of inadequacy of the valve anatomy to be 
repaired. Repair of chordae tendineae is condi- 
tioned by the limited surgical experience, the variety 
of operations used, and the lack of terminology to 
classify both subvalvular abnormalities and types of 
valvular procedures, as well as by the absence of 
long-term results with this kind of complex opera- 
tion. 
On the other hand, conservative surgery of the 
mitral valve orten implies repair of the leaflets, the 
anulus, and each structure of the subvalvular appa- 
ratus. In our study, an average of 2.7 procedures per 
patient was required to complete valve reconstruc- 
tion successfully. The presence of abnormalities of 
the chordae is frequently a major impediment to the 
repair of incompetent mitral valves by means of 
mitral valve annuloplasty alone. 
Although different attempts to repair chordae 
tendineae have been made in the United States as 
early as 1960,13' 14 chordal repair was eventually 
abandoned as a result of its unpredictable efficacy. 
The principles of mitral valve repair introduced by 
Carpentier and coworkers 15' 16 renewed interest in 
mitral valve reconstruction and encouraged various 
European and North American groups to use con- 
servative operations regularly. 1'17-21 Newer tech- 
niques were evolved and others were used with 
indications different from those originally intended. 
Mitral valve repair in rheumatic mitral valve 
disease is technically more ditficUlt and less stable 
than repair in ischemic and degenerative l sions 
because of the progressive nature of the pathologic 
condition and the type of patient population af- 
fected.4, 22, 23 This confirms the importance of re- 
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porting the results in patients with a homogeneous 
cause of the disease. 24-26 
Although our study, like others, 24'25 has shown 
the necessity to repair the subvalvular apparatus in 
most patients with rheumatic heart disease, the 
degree and extent of chordal involvement are pri- 
mary determinants of the likelihood of successful 
repair. Leaflet retraction is a most common finding 
in rheumatic mitral valve disease that frequently 
represents a major impediment for mitral valve 
repair. In our experience, only four patients with 
mild leaflet retraction were successfully treated by 
means of ring annuloplasty o increase leaflet coap- 
tation. Chordal elongation, a less common finding in 
these patients, is more suitabte for repair. Intraop- 
erative two-dimensionat and Doppler echocardiog- 
raphy done before cardiac operations provides a 
reliable assessment of the feasibility of valve repair 
versus replacement. 27 However, partial homograft 
replacement of the mitral valve is an alternative for 
patients with extensive rupture or elongation of 
marginal chordae, commissural involvement, and 
anterior leaflet disease that cannot be repaired by 
standard techniques. 28'29 
Advanced morphologic changes in the subvalvu- 
lar apparatus, progression of native valve disease, 
and lack of experience have been considered impor- 
tant risk factorS for failed mitral valve repair. 4' 23.30 
One of the arguments against this kind of operation 
is that chordal repair is time consuming and results 
in a rauch longer ischemic time and significantly 
higher hospital mortality than straight replacement. 
In the present study, however, the hospital mortaiity 
rate was lower than that for mitral valve replace- 
ment. 31 Long-term survival at 20 years has been 
lower in patients with polyvalvular disease than in 
patients with isolated mitral valve lesi0ns (52.1% ± 
18.6% versus 75.3% ± 13.3%). 
Thromboembolism has been the most common 
late postoperative complication in this group of 
patients. However, given that a substantial number 
of patients had polyvalvular disease with a high rate 
of preoperative risk factors, such as atrial fibrilia- 
tion, giant left atrium, previous thromboembolism, 
and left atrial thrombosis, the prevalence of postop- 
erative thromboembolic events has not been higher 
than that reported for bioprosthetic valve replace- 
ment. 3~ 
Only seven patients in this series underwent re- 
operation because of mitral valve dysfunetion. 
When valve insufficiency was the cause of failure, 
reoperation was done early in comparison with the 
timing of reoperation for restenosis (51 + 33.7 
months versus 194 _+ 33.2 months). These findings 
may indicate that in most cases residual insufficiency 
is a result of incorrect indication for repair, technical 
errors, or incomplete repair causing early valvular 
incompetence. Restenosis of the repaired mitral 
valve is usually a resuit of progression of rheumatic 
disease. A Doppler echographic study done during 
the closing interval showed, in 81.4% of patients, a
normal functioning mitrat valve, a mean valvular 
area of 1.9 ± 0.3 cm 2, and no evidence of valve 
incompetence. 
In ¢onclusion, repair of chordae tendineae in 
unselected patients with rheumatic mitral valve dis- 
ease when feasible has been shown to be a stable 
and safe procedure with acceptable long-term re- 
Sults, in particular with regard to a low prevalence of
reoperation. There are, however, insufficient data 
about the long-term results of this procedure in 
young populations with rheumatic disease. The type 
of reconstructive operation and experience of the 
surgical team are major considerations in the suc- 
cessful repair of the mitral valve. 
We are indebted to Carlos G. Durän, MD, for bis 
valuable active surgical participation i  the early series of 
patients. We thank Mrs. Charo Sänchez for secretarial 
help and Marta Pulido, MD, for editing the manuscript 
and editorial assistance. 
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